title: Re: weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
authors.forename: J
authors.initials: J
authors.lastname: Norsigian
authors.forename: M
authors.initials: M
authors.lastname: Napoli
authors.forename: B A
authors.initials: BA
authors.lastname: Brenner
authors.forename: N
authors.initials: N
authors.lastname: Cody
authors.forename: S
authors.initials: S
authors.lastname: Batt
authors.forename: C A
authors.initials: CA
authors.lastname: Pearson
authors.forename: L
authors.initials: L
authors.lastname: Potovsky-Beachell
authors.forename: V S
authors.initials: VS
authors.lastname: Cohen
mesh_terms: D001943:Breast Neoplasms / Q000517:prevention & control*; D005260:Female; D006801:Humans; D012306:Risk; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use*; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen